+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

From
From
From
From
From
From
AI in Oncology Market Insights, Analysis and Forecast 2026-2031 - Product Thumbnail Image

AI in Oncology Market Insights, Analysis and Forecast 2026-2031

  • Report
  • February 2026
  • 95 Pages
  • Global
From
From
From
From
From
From
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • November 2026
  • 88 Pages
  • Global
Global Oncology Market Strategic Research Report 2026-2031 - Product Thumbnail Image

Global Oncology Market Strategic Research Report 2026-2031

  • Report
  • August 2026
  • 328 Pages
  • Global
From
From
From
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more